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Tumor suppressor Pdcd4attenuates Sin1 translation to inhibit 
invasion in colon carcinoma
Qing Wang1, Jiang Zhu2, Ya-Wen Wang2, Yong Dai3, Yanlei Wang3, Chi Wang4,5, Jinpeng 
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1Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 
Lexington, Kentucky. 2Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, 
Shandong, China. 3Department of Colorectal and Anal Surgery, Qilu Hospital of Shandong 
University, Jinan, Shandong, China. 4Department of Biostatistics, College of Public Health, 
University of Kentucky, Lexington, Kentucky. 5Markey Cancer Center, College of Medicine, 
University of Kentucky, Lexington, Kentucky. 6Laboratory of Cancer Prevention, Center for Cancer 
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Abstract
Programmed cell death 4 (Pdcd4), a tumor invasion suppressor, is frequently down-regulated in 
colorectal cancer and other cancers. In this study, we find that loss of Pdcd4 increases the activity 
of mammalian target of rapamycin complex 2 (mTORC2) and thereby upregulates Snail 
expression. Examining the components of mTORC2 showed that Pdcd4 knockdown increased the 
protein but not mRNA level of stress-activated-protein kinase interacting protein 1 (Sin1), which 
resulted from enhanced Sin1 translation. To understand how Pdcd4 regulates Sin1 translation, the 
SIN1 5’ untranslated region (5’UTR) was fused with luciferase reporter and named as 5’Sin1-Luc. 
Pdcd4 knockdown/knockout significantly increased the translation of 5’Sin1-Luc but not the 
control luciferase without the SIN1 5’UTR, suggesting that Sin1 5’UTR is necessary for Pdcd4 to 
inhibit Sin1 translation. Ectopic expression of wild type Pdcd4 and Pdcd4(157–469), a deletion 
mutant that binds to translation initiation factor 4A (eIF4A), sufficiently inhibited Sin1 translation, 
and thus suppressed mTORC2 kinase activity and invasion in colon tumor cells. By contrast, 
Pdcd4(157–469)(D253A,D418A), a mutant that does not bind to eIF4A, failed to inhibit Sin1 
translation, and consequently failed to repress mTORC2 activity and invasion. In addition, directly 
inhibiting eIF4A with silvestrol significantly suppressed Sin1 translation and attenuated invasion. 
These results indicate that Pdcd4-inhibited Sin1 translation is through suppressing eIF4A, and 
functionally important for suppression of mTORC2 activity and invasion. Moreover, in colorectal 
cancer tissues, the Sin1 protein but not mRNA was significantly up-regulated while Pdcd4 protein 
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was down-regulated, suggesting that loss of Pdcd4 might correlate with Sin1 protein level but not 
mRNA level in colorectal cancer patients. Taken together, our work reveals a novel mechanism by 
which Pdcd4 inhibits Sin1 translation to attenuatemTORC2 activity and thereby suppresses 
invasion.
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INTRODUCTION
Programmed cell death 4 (Pdcd4) is a tumor suppressor, whose expression decreases in 
many types of cancers including colorectal cancer.1 Over-expression of Pdcd4 has been 
shown to inhibit cell proliferation,2 while Pdcd4 knockdown promotes cell proliferation,3 
suggesting an inhibitory role of Pdcd4 in regulating cell proliferation. Besides suppressing 
proliferation, several studies also demonstrated that Pdcd4 is a regulator of tumor invasion 
and metastasis. For instance, over-expression of PDCD4 cDNA attenuates invasion in colon 
and breast cancer cells.4–6 Conversely, Pdcd4 knockdown promotes invasion.7–9 Consistent 
with these in vitro findings, knockdown of Pdcd4 expression in colon tumor cells stimulates 
metastasis to lymph node and liver in nude mice,10 and knockout of Pdcd4 in mice induces 
lymphomas with frequent metastasis.11 We previously reported that Pdcd4 knockdown 
results in inhibition of E-cadherin expression and thereby activation of β-catenin and AP-1 
dependent transcriptions.7, 12 Suppression of E-cadherin expression in Pdcd4 knockdown 
cells is due to the stimulation of Snail expression since knockdown of Snail expression in 
Pdcd4 knockdown cells restored the expression of E-cadherin.7 However, how Snail 
expression is regulated by Pdcd4 remains unknown.
Pdcd4 also functions as a protein translation inhibitor. Biochemical and crystal structural 
analyses demonstrated that Pdcd4 binds with translation initiation factor 4A (eIF4A) and 
inhibits its helicase activity.13–15 The function of eIF4A, an ATP-dependent RNA helicase, 
is believed to unwind the mRNAs with secondary structure at 5’ untranslated region 
(5’UTR) at the stage of translation initiation.16 Since Pdcd4 inhibits eIF4A’s helicase 
activity, Pdcd4 is anticipated to preferentially suppress translation of mRNAs with 
secondary structure at 5’UTR. Indeed, by fusing a synthetic stem-loop structure at 5’UTR of 
luciferase, we demonstrated that Pdcd4 suppresses translation of this stem-loop structured 
luciferase greater than the one without it. Although Pdcd4 functions as an inhibitor for 
invasion and protein translation, the mechanism by which Pdcd4 inhibits translation to 
control tumor invasion is still unknown, and the Pdcd4 translational targets involved in 
tumor invasion have not been identified yet.
We and others have found that over-expression of PDCD4 cDNA inhibits phosphorylation of 
Akt at Ser473 while Pdcd4 knockdown activates Akt kinase activity and increases 
phosphorylation of Ser473,3, 17, 18 suggesting that Pdcd4 regulates Akt activity. Akt is 
frequently activated in many types of human cancers, which mediates numerous cellular 
functions including invasion and metastasis.19 The Akt activity is mainly regulated by 3-
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phosphoinositide-dependent kinase 1 (PDK1) and mammalian target of rapamycin (mTOR) 
complex 2 (mTORC2). Phosphorylation of Thr308 by PDK1 increases Akt kinase activity, 
but the maximal activity requires phosphorylation of Ser473 by mTORC2.20 mTOR 
associates with different subunits to form two distinct complexes, mTORC1 (mTOR 
complex 1) and mTORC2. mTORC1, which is rapamycin sensitive, enhances cell growth 
and proliferation.21 In contrast, mTORC2 is rapamycin insensitive and its biological 
functions remain understudied. mTORC2 is comprised of mTOR, rapamycin-insensitive 
companion of mTOR (Rictor), G protein beta subunit-like (GβL), stress-activated-protein 
kinase interacting protein 1 (Sin1), Protor-1, and Deptor.22 Recent studies suggest that 
mTORC2 is a critical regulator for cell motility, invasion, and metastasis. For instance, 
suppression of mTORC2 activity by knockdown of Rictor, attenuates colon tumor cell 
proliferation and invasion/metastasis in cultured cells as well as in nude mice,23, 24 while 
overexpression of Rictor elevates mTORC2 activity resulting in increased cell motility.25 
Sin1 is known as a unique component of mTORC2, and thought to stabilize the mTORC2 
complex by preventing it from undergoing lysosomal degradation.26 In addition, 
phosphorylation of Sin1 at Thr86 and Thr398 by S6K disrupts the binding between Sin1 and 
other mTORC2 components, resulting in decreased mTORC2 activity.27 
Immunohsitochemical staining also showed that Sin1 is up-regulated in the thyroid 
carcinomas and hepatocellular carcinoma.28, 29 Xu et al. demonstrate that depletion of Sin1 
expression reduces migration and invasion in hepatocellular carcinoma cells.29 However, 
little is known about the regulation of mTORC2 activity.
In this study, we identify that Sin1 is translationally regulated by Pdcd4 through eIF4A in 
colorectal cancer cells. We also demonstrate that Pdcd4-inhibited Sin1 translation results in 
suppression of mTORC2-Akt-Snail axis and thereby attenuation of colon tumor cell 
invasion. Manipulating eIF4A activity with pharmacological agent silvestrol also effectively 
inhibits Sin1 translation and tumor cell invasion. These findings suggest a novel mechanism 
of regulating invasion by Pdcd4 in colon tumor cells and provide a new direction for altering 
mTORC2 activity.
RESULTS
Loss of Pdcd4 activates mTORC2-Akt axis and enhances Snail expression
Previously, we demonstrated that Pdcd4 knockdown in colon carcinoma activates Akt kinase 
activity and concomitantly increases Snail expression to suppress E-cadherin expression and 
thereby promotes tumor invasion.3, 8, 12 To find out whether reduction of Pdcd4 expression 
in non-cancerous cells also activates Akt, we isolated the mouse embryonic fibroblast (MEF) 
cells from the embryos of wild-type and Pdcd4 knockout mice.30 The morphology of Pdcd4 
null MEF (Pdcd4−/−) cells appeared slightly longer and thinner comparing to the wild-type 
MEF (Pdcd4+/+) cells (Figure 1a), suggesting that Pdcd4 knockout triggered cytoskeleton 
rearrangement and might increase the cell motility. In agreement with the observation that 
Pdcd4 knockdown stimulates proliferation, the Pdcd4−/− MEF cells exhibited faster 
proliferation than Pdcd4+/+ MEF cells (Figure 1b). As expected, the phosphorylation of Akt 
at Ser473 was dramatically increased in Pdcd4−/− MEF cells as seen in Pdcd4 knockdown 
cells (HT29-P, HT29 cells expressing PDCD4 shRNA8) (Figure 1c). These findings suggest 
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that loss of Pdcd4 expression activates Akt. Next, we tested whether the Akt activation 
induced by Pdcd4 knockdown affected Snail expression. Akt has 3 isoforms, among which 
Akt1 and Akt2 are expressed in most tissues while Akt3 expression is restricted in brain and 
testis.31 Hence, we took Pdcd4 knockdown cells (HT29-P) and knocked down Akt1 and 
Akt2. Both significantly reduced Snail protein level, and consequently, upregulated its target 
E-cadherin (Figure 1d), suggesting that Pdcd4 knockdown activates Akt to increase Snail 
expression. In line with these results, activation of Akt by Pdcd4 knockdown or knockout 
also increased Snail expression (Figure 1c). It is known that mTORC2 can phosphorylate 
Akt at Ser473 to activate Akt.20 We, therefore, tested whether Pdcd4 knockdown activates 
mTORC2 kinase activity. As shown in Figure 1d, the mTORC2 kinase activity was 
approximately 3.5-fold higher in HT29-P cells than that in control cells (HT29-L, HT29 
cells expressing lacZ shRNA8), and in Pdcd4−/− MEF cells compared to wild type Pdcd4+/+ 
MEF cells (Figure 1e). These results indicate that loss of Pdcd4 enhances mTORC2-Akt 
axis, leading to the increased Snail expression.
Knockdown of Pdcd4 stimulates Sin1 translation
To explore the mechanism by which Pdcd4 affects mTORC2 activity, we examined the 
expression levels of individual components in mTORC2. The Sin1 protein in HT29-P cells 
was approximately 2.9-fold of that in HT29-L cells, while the protein levels of mTOR, 
Rictor, and GβL were alike in HT29-L and HT29-P cells (Figure 2a). Similar results were 
observed in Pdcd4−/− MEF cells in which Sin1 protein increased (Supplementary Figure S1). 
However, Pdcd4 knockdown did not affect either SIN1 mRNA level (Figure 2b) or Sin1 
protein stability (Figure 2c). In agreement with these results, over-expression of PDCD4 
cDNA in HCT116 and RKO cells decreased the protein level of Sin1 but not mTOR, Rictor, 
and GβL (Figure2d). These findings suggest that Pdcd4’s inhibition on Sin1 occurs at the 
posttranscriptional level and does not involve protein stability, presumably at the level of 
translation. To confirm this notion, we performed sucrose gradient fractionation to separate 
ribonucleoproteins (RNPs), monosomes, and polysomes. Knockdown of Pdcd4 resulted in a 
small reduction in free ribosomal subunits (Figure 2e). Polysomal fractions contain the 
actively translated mRNA bound with numerous ribosomes during protein translation. On 
the other hand, mRNA that is not translated or barely translated is distributed in RNPs and 
monosomal fractions. As shown in Figure 2f, SIN1 mRNA level increased 2 to 4-fold in 
heavier polysomal fractions (fractions #10–13) in HT29-P cells as compared to HT29-L 
cells. By contrast, there was no significant change in the distribution of RICTOR mRNA in 
polysomal fractions between HT29-P and HT29-L cells. In summary, these findings indicate 
that loss of Pdcd4 enhances Sin1 translation. Notably, Sin1 appeared as a single band in 
HCT116 cells but showed as two bands in RKO cells (Figure 2d). This discrepancy might be 
due to the existence of different isoforms in different type of cells.
The SIN1 5’UTR is essential for Pdcd4 to inhibit Sin1 translation
We have demonstrated that Pdcd4 directly binds with eIF4A and inhibits its helicase 
activity.15 eIF4A is a RNA helicase whose activity is required for translation of mRNAs with 
structured 5’UTR.32 Since the 5’UTR of SIN1 mRNA contains 330 nucleotides with high 
GC content which can form a stable secondary structure, translation of this type of mRNA is 
expected to be preferentially inhibited by Pdcd4. To test whether SIN1 5’UTR is an essential 
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element for inhibiting Sin1 translation by Pdcd4, we fused SIN1 5’UTR with luciferase 
reporter to generate 5’Sin1-Luc (Figure 3a) and transfected it into HT29-L and HT29-P 
cells. The luciferase activity in HT29-P cells was 1.8-fold of that in HT29-L cells (Figure 
3b), whereas the mRNA levels were about the same in both HT29-L and HT29-P cells 
(Figure 3c). Similar results were obtained when 5’Sin1-Luc was transfected into Pdcd4+/+ 
and Pdcd4−/− MEF cells, in which Pdcd4 knockout increased the luciferase activity about 
3.5-fold (Supplementary Figure S2). As expected, the luciferase activity is about the same in 
HT29-L and HT29-P cells when non-structured luciferase reporter (control) was transfected 
(Figure 3b), suggesting that Pdcd4 knockdown has no effect on luciferase enzymatic activity 
per se. Since the luciferase mRNA levels were similar between HT29-L and HT29-P cells 
(Figure 3c), the increase of luciferase activity should not be due to the increase in synthesis 
or stability of the luciferase mRNA but reflects translational enhancement. Moreover, 
transfection of the Pdcd4 expression plasmid along with 5’Sin1-Luc into HCT116 cells 
inhibited 5’Sin1-Luc translation in a concentration dependent manner, and the decrease in 
luciferase translation in 5’Sin1-Luc transfected cells was greater than that in control 
transfected cells (Figure 3d). These results suggest that SIN1 5’UTR is necessary for Pdcd4 
to inhibit Sin1 translation.
Pdcd4 suppresses Sin1 translation through inhibition of eIF4A
If Pdcd4 knockdown increases Sin1 translation through relieving the inhibition of eIF4A 
activity, then directly inhibiting eIF4A activity should reduce Sin1 translation. To test this, 
HT29-P cells were transfected with 5’Sin1-Luc and subsequently treated with eIF4A 
inhibitor, silvestrol, at a final concentration of 0 to 20 nM. The 5’Sin1-Luc translation in 
HT29-P cells treated with silvestrol decreased in a concentration dependent manner (Figure 
4a). Silvestrol at 20 nM inhibited approximately 50% of 5’Sin1-Luc translation, but did not 
affect translation of control luciferase reporter (Figure 4a). In addition, HT29-P cells treated 
with 20 or 50 nM of silvestrol showed a dramatic decrease in Sin1 and Snail abundances 
(Figure 4b). Similarly, exposing HCT116 cells to 20 or 50 nM of silvestrol also displayed a 
decrease in Sin1 and Snail protein levels. In concert with the result of polysomal 
fractionation, 20 or 50 nM of silvestrol did not affect the Rictor protein level (Figure 4b). 
These findings suggest that directly inhibiting eIF4A activity reverses Pdcd4 knockdown-
induced Sin1 translation. To further demonstrate that Pdcd4 inhibits Sin1 translation 
mediated by eIF4A, we transfected Pdcd4(WT), Pdcd4(157–469), and Pdcd4(157–469)
(D253A,D418A) along with 5’Sin1-Luc into HCT116 cells. Pdcd4(157–469), a deletion 
mutant containing amino acid residues 157 to 469, binds to eIF4A and inhibits translation, 
while Pdcd4(157–469)(D253A,D418A), the above deletion mutant with Asp residues 
substituted by Ala at 253 and 418, does not bind to eIF4A and fails to inhibit translation.33 
The full length Pdcd4(WT) and Pdcd4(157–469) inhibited 5’Sin1-Luc translation about 40% 
and 60%, respectively, comparing to empty vector (control, Figure 4c). By contrast, the cells 
expressing Pdcd4(157–469)(D253A, D418A) (Mut) had similar level of 5’Sin1-Luc 
translation as control cells. In addition, cells transfected with Pdcd4(WT) and Pdcd4(157–
469) showed a decrease in Sin1 and Snail abundances (Figure 4d). These results collectively 
suggest that Pdcd4 inhibits Sin1 translation by suppressing eIF4A activity and possibly 
impede the unwinding of the secondary structure in SIN1 5’UTR. It also indicates that 
Pdcd4 inhibits Snail abundance through suppression of Sin1 expression.
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Pdcd4-inhibited Sin1 translation leads to suppression of mTORC2 activity and invasion
Next, we asked whether up-regulation of Sin1 translation by Pdcd4 knockdown is 
functionally significant in promoting colon tumor cell invasion. We knocked down Sin1 
expression by two commercial SIN1 siRNAs, which reduced Sin1 protein levels about 80–
90%, and in consequence, phosphorylation of Akt at Ser473 and Snail expression were 
decreased (Figure 5a). As shown in Figure 5b, the invasive capacity of HT29-P cells 
transfected with SIN1 siRNA was approximately 40–50% of that in HT29-P cells 
transfected with scrambled siRNA (control), suggesting that Sin1 up-regulation triggered by 
Pdcd4 knockdown is important for promoting colon tumor cell invasion. To confirm that 
Pdcd4-inhibited Sin1 translation is sufficient for suppressing mTORC2 activity and invasion, 
we assayed the mTORC2 kinase activity and invasive capacity with the cells expressing 
Pdcd4 (WT), Pdcd4(157–469), and Pdcd4(157–469)(D253A, D418A). The Pdcd4(WT) 
significantly inhibited both mTORC2 kinase activity and invasive ability (Figures 5c and 5d) 
as well as migration ability (Supplementary Figure S3). The mTORC2 kinase activity and 
invasive capacity in cells expressing Pdcd4(157–469) were approximately 30% and 50% of 
that in cells expressing empty vector (control), respectively (Figures 5c and 5d). By contrast, 
the cells expressing Pdcd4(157–469)(D253A, D418A) had mTORC2 kinase activity and 
invasive capacity similar to that observed in control cells (Figures 5c and 5d). Together, 
these findings suggest that Pdcd4-inhibited Sin1 translation is critical for inhibition of 
mTORC2 activity and invasion.
To delineate the role of eIF4A in regulating cell invasion, we assayed the effects of silvestrol 
on invasion. HT29-P and HCT116 cells were serum starved for 24 h and subsequently 
seeded on the upper Boyden chamber with or without 20 nM of silvestrol. As shown in 
Figure 5e, silvestrol treatment markedly reduced cell ability to penetrate the Matrigel barrier, 
suggesting that inhibition of eIF4A activity suppresses invasion. In addition, 20 nM 
silvestrol sufficiently suppressed HT29-P and HCT116 cell migration (Supplementary 
Figure S4). It is noteworthy that HT29-P and HCT116 cells treated with 20 nM of silvestrol 
did not induce cell death (Figure 5f and Supplementary Figure S5) as observed in MDA-
MB-231 and PC-3 cells,34 indicating that the reduction in invasion was not due to silvestrol-
induced apoptosis.
Sin1 protein but not mRNA is up-regulated in the colorectal cancer tissues
To find out the expression status of Sin1 in human colorectal cancer, we examined the 
protein levels of both Sin1 and Pdcd4 in malignant colorectal tissues and adjacent normal 
colon tissues from 21 patients (Supplementary Table 1). The protein levels of Sin1 and 
Pdcd4 were assessed using immunoblot analysis. As shown in Figure 6a and Supplementary 
Figure S6, the Sin1 protein level was significantly elevated in the cancerous tissues 
compared to that in adjacent normal tissues. However, the SIN1 mRNA level was similar in 
cancerous and normal tissues (Figure 6b), indicating that elevation of Sin1 protein in 
colorectal cancer patients is not due to the increased Sin1 transcription. In contrast to up-
regulation of Sin1 protein, Pdcd4 protein level was down-regulated in the cancerous tissues 
(Figure 6c). These results suggest that loss of Pdcd4 might increase Sin1 protein but not 
mRNA in the colorectal cancer tissues as observed in cultured cells.
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DISCUSSION
The role of Pdcd4 in suppressing tumor invasion and metastasis has been established, but the 
molecular mechanism by which Pdcd4 inhibits invasion is not fully understood. In this 
study, we demonstrated that Pdcd4 suppressed Sin1 translation through inhibition of eIF4A 
mediated by SIN1 5’UTR, and Pdcd4-inhibited Sin1 translation is functionally significant in 
suppressing mTORC2-Akt-Snail axis and invasion. In agreement with these in vitro 
findings, the Sin1 protein but not mRNA increased and Pdcd4 protein decreased in 
colorectal cancer tissues. Thus, our results reveal a new mechanism of how Pdcd4 attenuates 
mTORC2 via inhibiting Sin1 translation to suppress colon tumor invasion (Figure 7).
Protein translational control is a critical step for regulation of cancer development. During 
translation initiation, the translation initiation complex binds to mRNA at 5’ end and scan 
mRNA to locate the translation initiation codon AUG. If the mRNA forms stable secondary 
structure at 5’UTR, it requires the eIF4A’s helicase activity to unwind such a structure 
allowing the translation initiation complex to pass through the secondary structure.32 
Inserting an artificial stem-loop structure at 5’UTR of luciferase, we previously found that 
Pdcd4 inhibited translation of luciferase with the stem-loop structure greater than the one 
without it. It thus implied that Pdcd4 preferentially inhibited translation of structured 
mRNAs at 5’UTR.33 This concept was applied to a natural mRNA in this study, in which we 
showed that Pdcd4 and Pdcd4(157–469) but not Pdcd4(157–469)(D253A,D418A) inhibited 
translation of 5’Sin1-Luc, and suppressing eIF4A by silvestrol inhibited 5’Sin1-Luc 
translation and Sin1 expression as well (Figure 4). These findings provide evidence that 
Pdcd4 represses the translation of its natural target, SIN1 mRNA, through SIN1 5’UTR.
Recent studies using genome-wide ribosome profiling revealed that eIF4A regulates a set of 
so-called “eIF4A-dependent transcripts”.35 Since the products of many eIF4A-dependent 
transcripts are transcription factors and oncogenes, inhibition of eIF4A is expected to 
suppress tumorigenesis. Indeed, inhibition of eIF4A activity by silvestrol suppresses tumor 
proliferation and induces apoptosis in various types of cancers.34, 36, 37 Although silvestrol 
has been demonstrated to effectively inhibit tumor growth, its role in tumor invasion is still 
unknown. Our findings that silvestrol efficiently inhibits eIF4A activity (Fig. 4) to suppress 
invasion in HCT116 and HT29-P cells (Figure 5) provide the evidence for silvestrol as an 
inhibitor for tumor invasion. Our results also showed that Pdcd4 inhibited invasion through 
inhibition of eIF4A, which is achieved, at least in part, by suppression of Sin1 translation 
since Pdcd4(157–469) but not Pdcd4(157–469)(D253A,D418A) sufficiently attenuated Sin1 
translation, mTORC2 activity, and invasion (Figures 3–5). In addition to inhibiting eIF4A 
activity, Pdcd4 has been reported to inhibit translation through an eIF4A-independent 
mechanism. Liwaket al. showed that Pdcd4 directly binds mRNAs of X-linked inhibitor of 
apoptosis and Bcl-x(L), and repressed their translations by preventing the formation of 
translation initiation complex.38 Fehler et al. also demonstrated that interaction between 
Pdcd4 and poly(A) binding protein is required for binding to C-MYB mRNA to suppress its 
translation.39 It is unknown whether Pdcd4 binds to mRNA through a specific motif or 
secondary structure, which needs further investigation.
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In colorectal cancer, the expression of mTOR, Rictor, and phospho-Akt (Ser473) are 
frequently up-regulated.40 Here, we showed that Sin1 protein level was also up-regulated in 
colorectal cancer tissues (Figure 6 and Supplementary Figure S6). Inactivation of mTORC2 
by Rictor knockdown23 or Sin1 knockdown (Figure 5) reduces colon tumor cell invasion, 
implying that mTORC2 activation is critical for promoting colorectal cancer cell invasion. In 
addition, our findings revealed that Pdcd4 inhibits mTORC2 activity and thereby suppresses 
Akt activation and Snail expression (Figure 1), suggesting that repression of mTORC2-Akt-
Snail axis by Pdcd4 contributes to invasion suppression (Figure 5). How does Akt regulate 
Snail expression? One potential path is through activation of NF-κB to up-regulate Snail 
expression.41 Akt induces phosphorylation of IκB, resulting in IκB degradation and thereby 
NF-kB activation. The other possible mechanism is that Akt inactivates GSK3 by 
phosphorylation of Ser21 in α subunit and Ser9 in β subunit, resulting in stabilization of 
Snail (Figure 7).42 Further investigation is needed to determine the downstream pathway of 
Pdcd4-mTOR2-Akt that regulates Snail expression. Dorrello et al. have shown that Pdcd4 
can be phosphorylated at Ser67 by p70S6K and subsequently undergoes proteasome 
degradation.43 Interestingly, Pdcd4 may inhibit p70S6K phosphorylation in turn.44 Here, we 
further demonstrated that Pdcd4 inhibits Akt activity by controlling mTORC2 (Figure 5), 
suggesting that Pdcd4 inhibits p70S6K phosphorylation by suppression of mTORC2-Akt 
axis.
Although mTORC2 has been implicated to be important for tumorigenesis, the regulation of 
mTORC2 activity is still not clearly known, especially in colorectal cancer. Recent studies 
suggested that p300-mediated acetylation of Rictor stimulates mTORC2 activity.45 In 
addition to Rictor, Sin1 also play an important role in regulating mTORC2 activity. Wei and 
colleagues reported that Sin1 binds to Ptdlns(3,4,5)P3 to translocate mTORC2 to plasma 
membrane and activate its activity.46 The same group also found that phosphorylation of 
Sin1 at Thr86 and Thr398 by either S6K or Akt interferes the binding of Sin1 to other 
mTORC2 components, resulting in inhibition of growth factor-induced mTORC2 
activation.27 However, James and colleagues reported that phosphorylation of Sin1 at Thr86 
activates mTORC2-Akt signalling and enhances mTORC2 kinase activity.47 It is not clear 
whether the discrepancy of these findings is due to the different cell-type or the kinase-
substrate specificity. Our findings that Pdcd4 inhibits Sin1 translation (Figure 2) and thus 
suppresses mTORC2 activation and invasion in colorectal cancer cells (Figure 5) provide a 
new regulatory mechanism of mTORC2 activity. This mechanism is further supported by the 
observations that Sin1 protein but not mRNA is up-regulated whereas Pdcd4 protein is 
down-regulated in human colorectal cancer tissues (Figure 6).
In conclusion, these results suggest that Pdcd4 inhibits Sin1 translation through eIF4A 
inhibition, which may repress the unwinding of secondary structure at SIN1 5’UTR. 
Inhibition of Sin1 translation leads to attenuation of mTORC2-Akt-Snail and invasion. 
These findings identify a new path to suppress mTORC2 via Pdcd4-inhibited Sin1 
translation, which points out a novel direction for development of mTORC2-specific 
inhibitors for cancer therapeutics.
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MATERIALS AND METHODS
Chemicals and reagents
Silvestrol was purchased from MedChem Express (Monmouth Junction, NJ) and dissolved 
in DMSO and stored at −80°C.
Cell lines and patient specimens
HT29, HCT116, and RKO cells were purchased from ATCC, and cultured in McCoy’s 5A 
medium as described previously.8 All cell lines were routinely tested for mycoplasma 
contamination. Tumor and adjacent normal tissues were obtained from 21 colorectal cancer 
patients at Qilu Hospital, Shandong University, China. Informed consent was obtained from 
all of patients. Both study protocol and informed consent were approved by the Ethical 
Committee of Qilu Hospital. Immediately after surgical removal, tumor and adjacent normal 
tissues were frozen in liquid nitrogen. Frozen tissues were grinded to fine powder and 
subsequently lysed in lysis buffer8 containing 1X protease inhibitor and phosphatase 
inhibitor cocktail with Dounce homogenizer for protein extraction. For RNA isolation, the 
tissue powder was incubated with Trizol (Invitrogen, Carlsbad, CA, USA) for 30 min with 
occasional vortex.
Isolation of MEF cells
The Pdcd4+/+ and Pdcd4−/− MEF cell lines were isolated from the embryos (day 13 or 14 
p.c.) of wild-type and Pdcd4 knockout mice,30 respectively. The embryos from placentas 
were passed through an 18G/1½" needle and cultured in 10 ml DMEM medium on a gelatin 
coated plate and incubated at 37°C until the cells reached confluence. The MEF are the only 
cells that attach and proliferate on the gelatin coated plate. At confluence, cells (Passage 0) 
were split at the ratio of 1:3. The primary MEF cells with passage 3 to 6 were used for the 
experiments.
Immunoblot analysis
Immunoblot analysis and quantification of band intensity were performed as described 
previously.8 The following primary antibodies were used for immunoblotting: anti-Akt1 
(#2938), anti-Akt2(#3063), anti-mTOR (#2972), anti-phospho-Akt (Ser473) (#4060), anti-
pan Akt (#4691), anti-Rictor (#2114), anti-Sin1 (NB110–40424), anti-GβL (#3274), anti-
Pdcd4, and anti-GAPDH (sc-47724). Antibody for Sin1 and GAPDH was purchased from 
Novus Biologicals (Littleton, CO, USA) and Santa Cruz (Santa Cruz, CA, USA), 
respectively. Akt1 and Akt2 antibodies were purchased from Pierce (Rockford, IL, USA). 
Pdcd4 antibody was generated previously.8 The rest of antibodies were purchased from Cell 
Signaling Technology (Danvers, MA, USA).
Quantitative real-time PCR
The total RNA was isolated from cells using Trizol reagent (Invitrogen). After synthesis first 
strand cDNA, the mRNA levels were quantified by quantitative PCR as described 
previously.8
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Sucrose gradient fractionation
Cells were treated with cyclohexamide (10 µg/ml) for 10 min prior to cell harvesting and 
lysed in the lysis buffer48 for 30 min on ice. After centrifugation, the supernatants were 
layered onto 10–45% (w/w) sucrose gradient containing 10 mM Tris-HCl (pH7.2), 60 mM 
KCl, 10 mM MgCl, 1 mM DTT, and 0.1 mg/ml of heparin. After centrifugation at 36,000 
rpm using SW41Ti rotor for 2 h, fractions were collected with Piston Gradient Fractionator 
(Biocomp, Fredericton, NB Canada) and monitored at 245 nm. The RNAs in each fraction 
were extracted using Trizol (Invitrogen)and subsequently analyzed using RT-qPCR.
mTORC2 kinase assay
Cells were lysed in CHAPS buffer49 containing protease inhibitors (Pierce) on ice for 30 
min. The lysate was incubated with mTOR antibody (Cell Signaling, #2972) and protein G 
magnetic beads (Pierce) at room temperature for 1h with constant rotary agitation. After 
wash with CHAPS buffer, the purified recombinant Akt1 (1 µl of 0.5 µg/ml, ATGen, Korea) 
and ATP (1 µl of 10 mM) and 18 µl of the mTORC2 kinase buffer49 were added to the 
beads, and incubated at 37°C for 15 min. The reaction was terminated by adding 20 µl of 
SDS sample buffer and boiled for 5 min to release the bound mTOR into the supernatant.
Migration and invasion assay
Migration and invasion assays were performed as described previously.8, 10
Statistical analysis
The levels of Sin1 and Pdcd4 protein, and SIN1 mRNAin malignant and adjacent normal 
tissues were analyzed by Wilcoxon signed rank test. For kinase activity assays, the one-
sample t-test was used to compare control and treated groups by examining whether the 
mean relative fold change is equal to one. For other experiments, the Bartlett’s test was first 
used to test for equal variances between groups. The Student’s t-test assuming equal 
variances was used to compare experimental groups if the Bartlett’s test was not significant, 
and the Welch’s unequal variances t-test was used otherwise. Data were expressed as mean ± 
SD. P< 0.05 was considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Loss of Pdcd4 upregulates Snail expression through mTORC2-Akt-Snail axis. (a) Images of 
wild type (Pdcd4+/+) and Pdcd4 null (Pdcd4−/−) MEF cells. (b) Pdcd4 knockout promotes 
cell proliferation. Pdcd4+/+ and Pdcd4−/− MEF cells were seeded onto 96-well plates at day 
0 (1.5×103 cells/well). The rate of cell growth was measured using XTT from day 1 to day 6. 
The value recorded at day 1 is designated as 1. Data were analyzed by Student t-test (n=4, 
mean±SD, ***P<0.001 vs Pdcd4+/+ at the same day). (c) Pdcd4 knockdown or knockout 
increases the phosphorylation of AKT at Ser473. Immunoblot analysis was performed using 
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indicated antibodies. (d) Knockdown of Akt1 and Akt2 inhibits Snail expression induced by 
Pdcd4 knockdown. HT29-P cells were transfected with scrambled siRNA, AKT1 siRNA, 
and AKT2 siRNA. Forty-eight hours post-transfection, lysates were collected and 
immunoblotted with the indicated antibodies. (e) Pdcd4 knockdown or knockout increases 
mTORC2 activation. Cell lysates from the indicated cells were subjected to 
immunoprecipitation with mTOR antibody and the precipitated complex was used for 
mTORC2 kinase assay followed by immunoblot to examine the level of phospho-
AKT(Ser473). Top, Image of representative mTORC2 kinase assay. Bottom, quantification 
of mTORC2 kinase activity with the ratio of phospho-Akt/precipitated mTOR in HT29-L 
and Pdcd4+/+ cells designated as 1. Data were analyzed by one-sample t-test (n=3; mean
±SD; *P<0.05).
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Figure 2. 
Pdcd4 knockdown enhances Sin1 translation. (a) Pdcd4 knockdown increases Sin1 protein 
expression. Cell lysates were probed with indicated antibodies in immunoblot analysis. The 
ratio of Sin1/GAPDH protein level in HT29-L cell is designated as 1.0. (b) Pdcd4 
knockdown has no impact on SIN1 mRNA level. The SIN1 mRNA levels were determined 
by RT-qPCR. The ratio of Sin1/GAPDH mRNA level in HT29-L cell is designated as 100%. 
Data were analyzed by one-sample t-test (n=3; mean±SD; n.s.= non-significant). (c) Pdcd4 
knockdown has no impact on Sin1 protein stability. Cells were treated with cycloheximide 
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from 0 to 24 h, and Sin1 protein levels were analyzed with immunoblot analysis. The level 
of Sin1/GAPDH in HT29-L or HT29-P at 0 h is designated as 1.0. (d) Overexpression 
ofPdcd4 inhibits Sin1 expression. HCT116 and RKO cells (5×105 per dish) were transfected 
with 5.0 µg of Pdcd4 expressing plasmid (pcDNA-Pdcd4). Cell lysates were used for 
immunoblot assay with antibodies against subunits of mTORC2. The ratio of Sin1/GAPDH 
in control HCT116 or RKO cells is designated as 1.0. (e) Polysomal profiles of sucrose 
gradient assay using HT29-L and HT29-P cells. (f) Pdcd4 knockdown increases distribution 
of SIN1 mRNA (top) but not RICTOR mRNA (bottom) in polysomal fractions. The mRNA 
level of Sin1/GAPDH and Rictor/GAPDH in HT29-L cells in each fraction is designated as 
1.
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Figure 3. 
The 5’UTRon sin1 mRNA is required for Pdcd4 to inhibit Sin1 translation. (a) Illustration of 
the 5’Sin1-Luc construct. (b and c) Pdcd4 knockdown increases SIN1 5’UTR luciferase 
activity (b) but not luciferase mRNA (c). HT29-L and HT29-P cells (5×104 per well) were 
transfected with 0.2 µg of 5’Sin1-Luc or pCMA-Luc (control) along with 20 ng of pRL-
SV40 (Promega). The normalized luciferase activity (firefly luciferase/Rinilla luciferase) in 
HT29-L cells is designated as 1. Data were analyzed by Welch’s t-test (n=5; mean ± SD; 
**P<0.01; ***P<0.001) for (b). The 5’Sin1-Luc mRNA levels were determined by RT-
qPCR and the level in HT29-L cells is designated as 100% (n=3; mean±SD; n.s.= non-
significant by one-sample t-test) in (c). (d) Pdcd4 inhibits 5’Sin1-Luc activity in a dose 
dependent manner. HCT116 cells (5 × 104 per well) were transfected with 0–1.5 µg of 
pcDNA-Pdcd4, 0.2 µg of 5’Sin1-LUC or pCMA-LUC (control), along with 20 ng of pRL-
SV40 (Promega). The total DNA for each transfection was maintained at 1.7 µg by adding 
pcDNA 3.1+ vector DNA. The normalized luciferase activity (firefly luciferase/Rinilla 
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luciferase) in cells transfected with 0 µg of Pdcd4 is designated as 100%. Data were 
analyzed by Student’s t-test (n=5; mean±SD; ***P<0.001).
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Figure 4. 
Pdcd4 suppresses Sin1 translation through inhibition of eIF4A. (a) Silvestrol inhibits the 
5’Sin1-Luc translation in a dose-dependent manner. The luciferase activity in cells treated 
with DMSO (0 nM silvestrol) is designated as 100%. Data were analyzed by Welch’s t-test 
(n=5; mean±SD; ***P<0.001). (b) Sin1 protein level decreases in cells treated with 
silvestrol. HT29-P or HCT116 cells were treated with indicated concentration of silvestrol 
for 24 h. The ratio of Sin1/GAPDH and Snail/GAPDH in DMSO (0 nM silvestrol) treated 
cells is designated as 1.0. (c) Pdcd4(157–469)(D253A,D418A) does not inhibit 5’Sin1-Luc 
activity. HCT116 cells (1 × 105 per dish) were transfected with 1.0 µg pCMV-HA (control) 
or plasmid expressing HA tagged WT or mutant Pdcd4, 0.2 µg of 5’Sin1-LUC, and 20 ng of 
pRL-SV40. The normalized luciferase (firefly luciferase/Rinilla luciferase) activity in cells 
transfected with pCMV-HA (control) is designated as 100%. Data were analyzed by Welch’s 
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t-test (n=5; mean±SD; *P<0.05; ***P<0.001). Mut: Pdcd4(157–469)(D253A,D418A). (d) 
Pdcd4(157–469)(D253A,D418A) does not inhibit Sin1 protein expression. HCT116 cells (6 
× 105) were transfected with 5.0 µg pCMV-HA (control) or plasmid expressing HA tagged 
WT or mutant Pdcd4. Seventy-two hours post-transfection, cell lysates were collected and 
subsequently immunoblotted with indicated antibodies. The ratio of Sin1/GAPDH and Snail/
GAPDH in pCMV-HA transfected cells (control) is designated as 1.0.
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Figure 5. 
Pdcd4 suppresses mTORC2 activity and invasion through inhibition of Sin1 translation. (a) 
Sin1 knockdown inhibits Akt phosphorylation in HT29-P cells. The Sin1 expression was 
knocked down by two commercial SIN1 siRNAs in HT29-P cells and the cell lysates were 
subjected to immunoblot analysis. The ratio of phospho-Akt/GAPDH and Snail/GAPDH in 
scrambled siRNA transfected cells (control) is designed as 1.0. (b) Sin1 knockdown in 
HT29-P cells decreases invasion. The HT29-P cells with Sin1 knockdown were serum 
starved for 24 h and subsequently assayed for invasive capacity. Left, representative images 
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of Matrigel invasion. Right, quantification of invasion. Cell proliferation was determined 
under the same conditions of invasion assay. Net invasiveness was measured as the ratio of 
invasion/proliferation with scrambled siRNA transfected cells as 100%. Data were analyzed 
by Student’s t-test (n=3; mean±SD; **P<0.01; ***P<0.001). (c and d) Pdcd4 inhibits 
mTORC2 kinase activity (c) or invasion (d) via inhibition of Sin1 translation. HCT116 cells 
(6 × 105 per dish) were transfected with 5.0 µg of pCMV-HA (control) or plasmid 
expressing HA tagged WT or mutant Pdcd4. Seventy-two hours post-transfection, cells were 
used for mTORC2 kinase and invasion assays. (c) Left, Image of representative mTORC2 
kinase assay. Right, quantification of mTORC2 kinase activity. The ratio of p-Akt/
precipitated mTOR in control cells is designated as 100%. Data were analyzed by one-
sample t-test (n=3; mean±SD; **P<0.01; ***P<0.001). (d) Left, the representative images of 
Matrigel invasion. Right, quantification of invasion. The net invasiveness was measured as 
the ratio of invasion/proliferation with control cells as 100%. Data were analyzed by 
Student’s t-test (n=3; mean±SD; *P< 0.05; **P<0.01). Mut: Pdcd4(157–469)(D253A, 
D418A). (e) Silvestrol treatment decreases the invasion capacity of tumor cells. Cells (2×105 
per well) were seeded on the Matrigel coated Boyden chamber and silvestrol was added to 
the upper and lower chambers to a final concentration of 20 nM. After 18h, the invasive cells 
were stained with 0.5% (v/w) crystal violet. Left, Representative images of the lower 
membrane surface. Right, quantification of invasion. The net invasiveness was measured as 
the ratio of invasion/proliferation with cells treated with DMSO as 100%. Data were 
analyzed by Student’s t-test (n=3; mean±SD; *P< 0.05; ***P<0.001). (f) No change of 
apoptosis rate in cells treated with silverstrol. Cells were treated with 20 nM of silvestrol for 
24 h and subsequently assayed for apoptosis using annexin V-FITC. Data were analyzed by 
student’s t-test (n=3; mean±SD; n.s.= non-significant).
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Figure 6. 
Sin1 protein but not mRNA is up-regulated in the human colon cancer tissues. (a and c) The 
Sin1 protein level is up-regulated (a) and Pdcd4 protein level is down-regulated (c) in 
malignant tissues compared to the adjacent normal tissues. Protein levels of Sin1 and Pdcd4 
in 21-patient specimens were analyzed with immunoblot analysis. The value of Sin1/actin 
(a) and Pdcd4/actin (c) was used for statistical comparison by Wilcoxon signed rank test 
(Sin1, P=9.5×10−7; Pdcd4, P=9.5×10−7). (b) The level of SIN1 mRNA is similar in normal 
and malignant tissues .The SIN1 mRNA level in 21-patient specimens was analyzed by RT-
qPCR. The value of SIN1/GAPDH in each sample was used for statistical comparison 
(Wilcoxon signed rank test, P=0.24).
Wang et al. Page 24
Oncogene. Author manuscript; available in PMC 2018 January 10.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Figure 7. 
Schematic diagram showing that Pdcd4 suppresses Sin1 translation to inhibit mTORC2 
activity leading to suppression of invasion. Pdcd4 suppresses Sin1 translation via inhibition 
of eIF4A. Inhibition of eIF4A by silvestrol also suppresses Sin1 translation. The inactivation 
of mTORC2 by Pdcd4 or silvestrol leads to Akt inhibition, then either inhibits NF-κB or 
GSK3, and thus reduces Snail expression, which ultimately suppresses invasion.
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